Skip to main content

Table 1 Effects of Rimonabant with dietary intervention on physical and biochemical parameters over the study period (n = 20) (Mean ± SD)

From: Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant

 

Baseline

6 Months

Weight (Kg)

112 ± 21

107 ± 21***

Waist circumference (cm)

124 ± 13

121 ± 13**

Fat mass (Kg)

44 ± 12

42 ± 12

HbA1c (%)

8.0 ± 1.6

7.4 ± 1.7*

Total cholesterol (mmol/L)

4.4 ± 1.0

4.4 ± 1.0

LDL cholesterol (mmol/L)

2.3 ± 0.8

2.4 ± 0.9

HDL cholesterol (mmol/L)

1.2 ± 0.2

1.3 ± 0.2**

Triglyceride (mmol/L)

1.9 ± 1.1

1.7 ± 0.9

Insulin dose (units / day)

116 ± 59

102 ± 71*

Systolic blood pressure (mmHg)

147 ± 21

142 ± 24

Diastolic blood pressure (mmHg)

85 ± 8

83 ± 11

  1. *p < 0.05 in comparison to baseline.
  2. **p < 0.01 in comparison to baseline.
  3. ***p < 0.001 in comparison to baseline.